Entasis Therapeutics Holdings Inc.

NasdaqGM:ETTX Stok Raporu

Piyasa değeri: US$104.8m

This company has been acquired

The company may no longer be operating, as it has been acquired. Find out why through their latest events.

Entasis Therapeutics Holdings Yönetim

Yönetim kriter kontrolleri 2/4

Anahtar bilgiler

Manos Perros

İcra Kurulu Başkanı

US$2.0m

Toplam tazminat

CEO maaş yüzdesi27.0%
CEO görev süresi7.2yrs
CEO sahipliği0.2%
Yönetim ortalama görev süresi3yrs
Yönetim Kurulu ortalama görev süresi4.3yrs

Son yönetim güncellemeleri

Recent updates

Will Entasis Therapeutics Holdings (NASDAQ:ETTX) Spend Its Cash Wisely?

Dec 16
Will Entasis Therapeutics Holdings (NASDAQ:ETTX) Spend Its Cash Wisely?

Entasis Therapeutics: AstraZeneca Spin-Out Developing Targeted Antibacterial Products

Nov 17

Is Entasis Therapeutics Holdings (NASDAQ:ETTX) In A Good Position To Invest In Growth?

Aug 19
Is Entasis Therapeutics Holdings (NASDAQ:ETTX) In A Good Position To Invest In Growth?

Entasis Therapeutics shares rise after lining up ETX0462 poster presentation

Jun 18

What Kind Of Shareholders Own Entasis Therapeutics Holdings Inc. (NASDAQ:ETTX)?

Feb 17
What Kind Of Shareholders Own Entasis Therapeutics Holdings Inc. (NASDAQ:ETTX)?

Is Entasis Therapeutics Holdings (NASDAQ:ETTX) In A Good Position To Invest In Growth?

Dec 01
Is Entasis Therapeutics Holdings (NASDAQ:ETTX) In A Good Position To Invest In Growth?

CEO Tazminat Analizi

Manos Perros'un ücretlendirmesi Entasis Therapeutics Holdings'un kazancına kıyasla nasıl değişti?
TarihToplam TazminatMaaşŞirket Kazançları
Mar 31 2022n/an/a

-US$52m

Dec 31 2021US$2mUS$553k

-US$47m

Sep 30 2021n/an/a

-US$46m

Jun 30 2021n/an/a

-US$45m

Mar 31 2021n/an/a

-US$46m

Dec 31 2020US$1mUS$537k

-US$50m

Sep 30 2020n/an/a

-US$54m

Jun 30 2020n/an/a

-US$46m

Mar 31 2020n/an/a

-US$46m

Dec 31 2019US$1mUS$495k

-US$44m

Sep 30 2019n/an/a

-US$38m

Jun 30 2019n/an/a

-US$52m

Mar 31 2019n/an/a

-US$44m

Dec 31 2018US$2mUS$450k

-US$42m

Sep 30 2018n/an/a

-US$43m

Jun 30 2018n/an/a

-US$34m

Mar 31 2018n/an/a

-US$35m

Dec 31 2017US$1mUS$430k

-US$30m

Dec 31 2016US$761kUS$413k

-US$19m

Tazminat ve Piyasa: Manos 'nin toplam tazminatı ($USD 2.05M ), US pazarındaki benzer büyüklükteki şirketler için ortalamanın üzerindedir ($USD 647.72K ).

Tazminat ve Kazançlar: Manos şirketinin tazminatı, şirket kârsız olduğu sürece artırıldı.

CEO

Manos Perros (54 yo)

7.2yrs

Görev süresi

US$2,047,687

Tazminat

Dr. Manoussos Perros, Ph D., also known as Manos, serves as the Chief Executive Officer, President & Director at Entasis Therapeutics Inc. Dr. Perros has been President, Chief Executive Officer and Directo...

Liderlik Ekibi

İsimPozisyonGörev süresiTazminatSahiplik
Manoussos Perros
President7.2yrsUS$2.05m0.17%
$ 174.7k
Ruben Tommasi
Chief Scientific Officer7.2yrsUS$998.39k0.098%
$ 103.0k
David Altarac
Chief Medical Officer2.7yrsUS$1.09m0.052%
$ 54.7k
Kristie Wagner
Interim VP and Interim Principal Financial & Accounting Officerless than a yearVeri yokVeri yok
Elizabeth Keiley
General Counsel3.3yrsVeri yok0.35%
$ 367.0k
John Mueller
Chief Development Officer7.2yrsUS$754.14k0.35%
$ 365.9k
Matthew Ronsheim
Chief Pharmaceutical Sciences & Manufacturing Officer1.8yrsVeri yok0.35%
$ 367.0k
Anna Triola
Chief Commercial Officerless than a yearVeri yok0.26%
$ 273.7k

3.0yrs

Ortalama Görev Süresi

55.5yo

Ortalama Yaş

Deneyimli Yönetim: ETTX 'un yönetim ekibi deneyimli olarak değerlendirilmektedir (ortalama görev süresi 3 yıldır).

Yönetim Kurulu Üyeleri

İsimPozisyonGörev süresiTazminatSahiplik
Manoussos Perros
President7.2yrsUS$2.05m0.17%
$ 174.7k
David Hastings
Independent Director4.3yrsUS$153.23k0.046%
$ 48.2k
Louis Rice
Member of Scientific & Clinical Board1.9yrsVeri yokVeri yok
Heather Preston
Independent Director4.9yrsUS$49.00kVeri yok
Karen Bush
Member of Scientific & Clinical Boardno dataVeri yokVeri yok
Helen Boucher
Member of Scientific & Clinical Boardno dataVeri yokVeri yok
Howard Mayer
Independent Director2.9yrsUS$123.05k0.046%
$ 48.2k
Heather Berger
Independent Director4.9yrsUS$132.33k0.046%
$ 48.2k
Paul Ambrose
Member of Scientific & Clinical Boardno dataVeri yokVeri yok
David Meek
Independent Chairman of the Board3.1yrsUS$174.28k0.046%
$ 48.2k
Mark Noe
Member of Scientific & Clinical Boardno dataVeri yokVeri yok
Andrew Shorr
Member of Scientific & Clinical Boardno dataVeri yokVeri yok

4.3yrs

Ortalama Görev Süresi

57.5yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: ETTX 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 4.3 yıldır).